There are several ways for pharmaceuticals for treating multiple sclerosis (MS) to reach the market. Novel pharmaceuticals cannot enter the US market without...

clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis. There are also trials...

Multiple sclerosis (MS) is an autoimmune disease resulting in damage to myelin – the insulating covers of nerve cells – in the brain and spinal cord. As...

potassium channel. It has also been used as a drug, to manage some of the symptoms of multiple sclerosis, and is indicated for symptomatic improvement...

Generic drug names are given in parentheses following the brand name. – Autoimmune Aubagio (Teriflunomide), small molecule for multiple sclerosis. Approved...

overall drug spend would have increased only 6.4%. The cost of "the top three specialty therapy classes—inflammatory conditions, multiple sclerosis and...

approved by the U.S. Food and Drug Administration (FDA) as a treatment option for adults with relapsing multiple sclerosis (brand name Tecfidera). In 2017...

Consortium of Multiple Sclerosis Centers and the Americas Committee for Treatment and Research in Multiple Sclerosis. Retrieved 4 June 2012. "Drug Approval...

particularly for multiple sclerosis using BHT-3009, and type 1 diabetes mellitus. Possible applications of inverse vaccines include: Multiple Sclerosis (MS) Type...

episodes) was conducted. Phase I/II trial for primary progressive multiple sclerosis concluded that Idebenone did not inhibit disability progression. As...

Multiple Sclerosis Discovery Forum (MSDF) is a non-profit online resource created to speed progress toward a cure for multiple sclerosis (MS) and other...

amphetamine and nomifensine in animals. Amantadine is widely used to treat multiple sclerosis-related fatigue, among other fatigue- and motivation-related disorders...

and clinical pharmacology information on the multiple sclerosis drug. That delayed approval of a key pipeline prospect with forecast peak sales of around...

announced that its drug Fampyra converted from conditional marketing authorization to standard marketing approval. EU multiple sclerosis (MS) patients use...

Office of the (11 September 2019). "FDA approves new oral drug to treat multiple sclerosis". FDA. Archived from the original on 9 February 2021. Retrieved...

Age Subgroups in Adults with Relapsing Multiple Sclerosis". celgene.com. Retrieved 2019-05-11. Celgene´s Pipeline, retrieved 2019-05-12 Teller, Sara E....

treatment of chronic pain of multiple sclerosis, cancer, hypertension, or the treatment of obesity. A clinical trial with this drug was underway in Rennes,...

of Cannabis approved as a botanical drug in the United Kingdom as a mouth spray for people with multiple sclerosis, who can use it to alleviate neuropathic...

daclizumab in indications it had never licensed to Roche, including multiple sclerosis. Facet partnered that development program with Biogen Idec which attempted...

Amyotrophic Lateral Sclerosis (ALS)" at ClinicalTrials.gov Scholia has a topic profile for Pyrimethamine. "Pyrimethamine". Drug Information Portal. U...

past. Various drugs that inhibit BTK are in clinical trials: Phase 3: Evobrutinib for multiple sclerosis. Tolebrutinib, for multiple sclerosis. Remibrutinib...

disease-modifying therapies for autoimmune diseases such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Research efforts were also focused...

patents on multiple drugs, including Copaxone, a specialty drug (for the treatment of multiple sclerosis), now the world's best selling MS drug, and Azilect...

targeting neuromuscular diseases such as ALS and multiple sclerosis. Helixmith also has an antibody pipeline including VM507, an antibody that can detect...

In July 2014, Genentech/Roche acquired Seragon for its pipeline of small-molecule cancer drug candidates for $725 million cash upfront, with an additional...

Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation...

in that time." In 2005, the last time they brought a new drug to market (multiple sclerosis treatment Tysabri). Tysabri was "quickly pulled from the market...

multiple sclerosis, and stroke, and was being explored as a treatment for cerebral vasospasm, head trauma, kidney transplantation, and restenosis. Multiple companies...

Research, he helped create a drug pipeline for neuropsychiatric diseases, introduced human stem cell models as tools for drug discovery in neuroscience and...

that the multiple sclerosis drug Gilenya might also be a treatment for ALS, the Institute enrolled 30 people in a Phase 2A clinical trial the drug in 2013...